行业分析 |
|
|
|
|
抗肿瘤药物市场概述 |
李敏1, 吴日伟2 |
1 江西省科学院科技战略研究所 南昌 330096; 2 南昌高新技术产业开发区管理委员会 南昌 330096 |
|
Overview on the Antineoplastic Drugs Market |
LI Min1, WU Ri-wei2 |
1 Institute of Science and Technology Strategy, Jiangxi Academy of Sciences, Nanchang 330096, China; 2 National High-Tech Industrial Development, Nanchang 330096, China |
[1] 陈雪静. 抗肿瘤抗体药物的研究进展. 中国生物制品学杂志, 2015, 28(1):84-90. Chen X J. Advances in research on therapeutic antibodies against tumors. Chinese Journal of Biologicals, 2015, 28(1):84-90. [2] 于元元, 冯柳, 刘京京, 等. 抗肿瘤药物全球市场分析. 药事管理, 2013, 48(2):155-158. Yu Y Y, Feng L, Liu J J, et al. Global market analysis on antitumor drugs. Chinese Pharmaceutical Journal, 2013, 48(2):155-158. [3] Kinch M S. An analysis of FDA-approved drugs for oncology. Drug Discover Today, 2014, 19(12):1831-1835. [4] 胡宏祥, 王学清, 张华, 等. 分子靶向抗肿瘤药物的作用机制及临床研究进展. 药学学报, 2015, 50(10):1232-1239. Hu H X, Wang X Q, Zhang H. et al. Mechanism and clinical progress of molecular targeted cancer therapy. Acta Pharmaceutica Sinica, 2015, 50(10):1232-1239. [5] 宋洋. 国际抗肿瘤药物市场趋势. 科技信息, 2013, 21:462-463. Song Y. Analysis of international anticancer drug market trends. Science & Technology Information, 2013, 21:462-463. [6] 熊杏安, 王宗喜. 分子靶向抗肿瘤药物研究进展. 长江大学学报, 2014, 11(21):103-105. Xiong X A, Wang Z X. The study progress of molecular-targeted antitumor drugs. Journal of Yangtze University. 2014, 11(21):103-105. [7] Dietel M, Johrens K, Laffert M, et al. Predictive molecular pathology and its role in target cancer therpy:a review focussing on clinical relevance. Cancer Gene Therpy, 2013, 20(4):211-221. [8] 柏静, 杨长福, 黄高, 等. 小分子靶向抗肿瘤药物的研究进展. 肿瘤药学, 2015, 5(3):168-173. Bai J, Yang C F, Huang G, et al. Research progress of small-molecule targeted anti-tumor drugs. Anti-tumor Pharmacy, 2015, 5(3):168-173. [9] Chen W, Zheng R, Baade P D, et al. Cancer statistics in China. CA:A Cancer Journal for Clinicians, 2016, 66(2):115-132. [10] 刘姹. 重磅抗癌药市场之中国特色. 医药经济报, 2016, 6月24日,第004版. Liu CH. The Chinese characteristics of the blockbuster cancer drug market. Medicine Economic Report, 2016, 6,24,004. [11] 于小婷, 韩晟, 张慕禹, 等. 我国医疗机构抗肿瘤药物行业集中度分析. 中国药杂志, 2013, 22(24):2852-2855. Yu X T, Han S, Zhang M Y, et al. Concentration ratio analysis of antineoplastic drugs from medical institutions in China. Chinese Journal of New Drugs, 2013, 22(24):2852-2855. [12] 吴志. 抗肿瘤药挺进"廉价箱". 科技日报, 2013,5月2日,第005版. Wu Z. Anti-tumor drugs advance into the "cheap box". Science and Technology Daily, 2013,5,2,005. [13] 田红, 肖桂芝, 刘永贵. 抗肿瘤药物市场分析. 现代药物与临床, 2013, 28(3):424-427. Tian H, Xiao G Z, Liu Y G. Market analysis on antitumor drugs. Drugs & Clinic, 2013, 28(3):424-427. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|